The methylation signature within MS lesions suggests a potential differentiation and (re)myelination block, directly acting on essential myelin genes, such as MBP. However, as the Illumina EPIC array was performed on bulk tissue, the observed degree of methylation of MBP could also be explained by cellular heterogeneity of the samples. This evidence concerns the gene MBP and myeloid sarcoma.